Jazz Pharmaceuticals plc 4
4 · Jazz Pharmaceuticals plc · Filed Mar 8, 2017
Insider Transaction Report
Form 4
Treacy Paul
SVP, Technical Operations
Transactions
- Sale
Ordinary Shares
2017-03-06$131.97/sh−355$46,851→ 18,108 total - Sale
Ordinary Shares
2017-03-06$131.97/sh−529$69,815→ 17,579 total
Footnotes (3)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.4935 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.5330 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.